China In–Vitro Diagnostics  Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose, Point of Care Testing ], Companies

China In–Vitro Diagnostics Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose, Point of Care Testing ], Companies

  • August 2018 •
  • 102 pages •
  • Report ID: 5490292 •
  • Format: PDF
China In–Vitro Diagnostics (IVD) Market is projected to exceed US$ 12 Billion by the end of year 2024.
China In–Vitro Diagnostics (IVD) Market is growing significantly and is expected to continue its ongoing trend during the forecast period as well, owing to rapidly increasing middle class population who is now willing to pay more for better healthcare services and aging population who are more vulnerable to contagious diseases. Also, Chinese aging population is experiencing an outburst of chronic diseases which includes cancer, diabetes and cardiovascular disease. All of these diseases can be diagnosed and monitored using IVD products.

In addition; some other factors which can be attributed to China IVD market include growing prevalence of chronic lifestyle and infectious diseases, public health awareness, transformation of medical models, increasing demand of tests from the rural areas and support from the Chinese government to provide better healthcare infrastructure throughout the nation.

Renub Research report titled “China In–Vitro Diagnostics (IVD) Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market.

By Segment – Immunoassay and Clinical Chemistry dominates the China IVD Market
The report studies the market of the following In–Vitro Diagnostics (IVD) segments: Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), and Point of Care Testing (POCT).

Companies Analysis
Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories are some of the top companies operating in the China IVD Market; which has been studied thoroughly in the report.

The report China In–Vitro Diagnostics (IVD) Market has been studied from 7 viewpoints:

1) Market & Forecast
2) Segment Wise Market & Forecast
3) Development Environment & Regulatory Status in China IVD market
4) Company-wise IVD Sales & Forecast
5) Profiles of Private Clinical Labs and Diagnostic Services
6) Growth Drivers for China In-Vitro Diagnostics
7) Challenges for China In-Vitro Diagnostics

This market research report provides a complete analysis of the China In-Vitro Diagnostics (IVD) Market, Growth Drivers, Challenges, and their projections for the upcoming years.

By Segment
1. Clinical Chemistry
2. Immunoassay
3. Hematology
4. Coagulation
5. Microbiology
6. Molecular Testing
7. Self Monitoring of Blood Glucose (SMBG)
8. Point of Care Testing (POCT)
Companies Covered in the Report:
1. Roche Diagnostics
2. Sysmex Corporation
3. Mindray Medical International Limited
4. Shanghai Kehua Bio-Engineering Co. Ltd.
5. Abbott Laboratories
6. Others

Profiles of Private Clinical Labs and Diagnostic Services Companies in China
• Zhejiang Di’an Diagnostics Technology Co., Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI-Shenzhen (Privately held)
• OriGene Technologies (Privately held)